About diaDexus
Diadexus, Inc. is a diagnostics company. The Company is engaged in developing and commercializing products that deliver healthcare providers with relevant information to assist in the management of their patients throughout the course of cardiac disease. Its capabilities include manufacturing, assay development, Food and Drug Administration (FDA) regulatory clearance, and marketing and selling products. Its commercially-available products consist of two FDA-cleared tests to measure Lp-PLA2: the PLAC Test ELISA Kit (the PLAC ELISA Test) and the PLAC Test for Lp-PLA2 Activity (the PLAC Activity Test). Its other products include proADM; proET-1, which aids in predication of heart failure, and proANP, which aids in predication of heart failure. The Company sells its diagnostic products to laboratories and promotes these products to the laboratories' sales representatives, as well as directly to healthcare providers.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: OTCMKTS
- Symbol: DDXS
- CUSIP:
Key Metrics:
- Previous Close: $0.01
- 50 Day Moving Average: $1.11
- 200 Day Moving Average: $1.54
- 52-Week Range: $0.01 - $5.40
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -0.01
- P/E Growth: 0.00
- Market Cap: $N/A
Additional Links:
Consensus Ratings for diaDexus (OTCMKTS:DDXS) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for diaDexus (OTCMKTS:DDXS)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 8/14/2015 | Feltl & Co. | Downgrade | Buy -> Hold | |  |
| 2/19/2015 | Ladenburg Thalmann | Upgrade | Buy | | |
(Data available from 9/28/2014 forward)
Earnings History for diaDexus (OTCMKTS:DDXS)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 8/11/2016 | | | | | | | | |
| 10/26/2015 | | ($0.69) | ($0.34) | | | View | N/A | |
| 8/13/2015 | | ($0.29) | ($0.87) | | | View | N/A | |
| 5/12/2015 | Q115 | ($0.04) | ($0.02) | $5.23 million | | View | N/A | |
| 3/11/2015 | | ($0.02) | ($0.04) | | | View | N/A | |
| 11/5/2014 | | ($0.01) | ($0.03) | | | View | N/A | |
| 7/28/2014 | | ($0.02) | ($0.01) | | | View | N/A | |
| 5/7/2014 | | ($0.03) | ($0.07) | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for diaDexus (OTCMKTS:DDXS)Current Year EPS Consensus Estimate: $-1.50 EPS
Next Year EPS Consensus Estimate: $-1.50 EPS
Dividend History for diaDexus (OTCMKTS:DDXS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for diaDexus (OTCMKTS:DDXS)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for diaDexus (OTCMKTS:DDXS)
diaDexus (OTCMKTS:DDXS) Chart for Wednesday, September, 28, 2016
